A novel Shiga toxin 2a neutralizing antibody therapeutic with low immunogenicity and high efficacy
Antimicrobial Agents and Chemotherapy · 2024
DOI: 10.1128/aac.00598-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Marina E Kirkland und 4 weiteren Autor:innen. Beteiligte Einrichtung: United States Department of Agriculture, Agricultural Research Service, Western Regional Research Center , Albany, California, USA. Hauptthemen laut MEDLINE: Escherichia coli Infections, Shiga-Toxigenic Escherichia coli, Hemolytic-Uremic Syndrome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: U.S. Department of Agriculture (USDA), U.S. Department of Energy (DOE).
Abstract (Originalsprache)
Shiga toxin-producing Escherichia coli infections are difficult to treat due to the risk of antibiotic-induced stress upregulating the production of toxins, medical treatment is consequently limited to supportive care to prevent the development of hemolytic uremic syndrome (HUS). Here, we introduce a potentially therapeutic humanized mouse monoclonal antibody (Hu-mAb 2-5) targeting Stx2a, the most common Shiga toxin subtype identified from outbreaks. We demonstrate that Hu-mAb 2-5 has low immunogenicity in healthy adults ex vivo and high neutralizing efficacy in vivo , protecting mice from mortality and HUS-related tissue damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- United States Department of Agriculture, Agricultural Research Service, Western Regional Research Center , Albany, California, USA.
- U.S. Department of Energy, Oak Ridge Institute for Science and Education , Oak Ridge, Tennessee, USA.
ORCID-Profile: Marina E Kirkland, Xiaohua He
Förderung
- U.S. Department of Agriculture (USDA)
- U.S. Department of Energy (DOE)
Zitieren
APA
Kirkland, M. E., Patfield, S., Hughes, A. C., Hernlem, B., & He, X. (2024). A novel Shiga toxin 2a neutralizing antibody therapeutic with low immunogenicity and high efficacy. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00598-23
Vancouver
Kirkland ME, Patfield S, Hughes AC, Hernlem B, He X. A novel Shiga toxin 2a neutralizing antibody therapeutic with low immunogenicity and high efficacy. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00598-23
BibTeX
@article{Kirkland2024,
author = {Kirkland, Marina E and Patfield, Stephanie and Hughes, Anna C and Hernlem, Bradley and He, Xiaohua},
title = {A novel Shiga toxin 2a neutralizing antibody therapeutic with low immunogenicity and high efficacy},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2024},
doi = {10.1128/aac.00598-23}
}
EUVIMED